Petrichor Biopharma Consulting
Strategic Advisory Services in Oncology R&D
About Megan O'Meara
Megan O'Meara MD, Founder and Principal, is a board-certified Medical Oncologist and senior biopharmaceutical executive with over 15 years of global leadership experience, with a proven track record advancing multiple novel therapies from discovery through regulatory approval at leading organizations including Pfizer and Seagen. Petrichor Biopharma Consulting provides strategic advisory and consulting services to biotech companies, VC firms, and investors focused on oncology R&D.
The firm specializes in helping biotech leadership, investors, and boards navigate complex oncology development challenges. Whether optimizing your pipeline strategy, evaluating investment opportunities through rigorous diligence, or providing high-touch fractional executive leadership, Petrichor brings deep expertise in clinical development, translational medicine, and cross-functional team leadership.
Our Services
Portfolio & Development Strategy
Comprehensive pipeline prioritization, IND-enabling strategy, and regulatory roadmap optimization. I can help biotechs make data-driven decisions on which portfolio strategy, clinical development plans, and regulatory pathways.
Business Development & Investment Diligence
Strategic diligence for M&A, licensing, and venture investments. I can provide buy-side and sell-side risk evaluation, asset valuation support, and strategic guidance for sound investment decisions and successful BD&L transactions.
Executive Leadership & Governance
Scientific Advisory Board leadership, and independent board director governance, and pre-IND Fractional CMO services. I provide experienced executive guidance to strengthen portfolio governance, talent development, and stakeholder relations.